Efficacy and Safety of Anti-HER2 Agents in Combination with Chemotherapy for Metastatic HER2-positive Breast Cancer Patient: A Network Meta-analysis

Sarcoid-like reaction in a HER2-positive breast cancer patient: A case report

International Journal of Surgery Case Reports ◽

10.1016/j.ijscr.2021.106280 ◽

2021 ◽

pp. 106280

Author(s):

Chikako Sekine ◽

Kazumi Kawase ◽

Kazuhiko Yoshida

Keyword(s):

Breast Cancer ◽

Case Report ◽

Cancer Patient ◽

Breast Cancer Patient ◽

Her2 Positive ◽

Repeated courses of radiation treatment in an HER2‐positive breast cancer patient with diffuse brain metastases: A case report

The Breast Journal ◽

10.1111/tbj.13844 ◽

2020 ◽

Vol 26 (7) ◽

pp. 1370-1371

Author(s):

Sonia Silipigni ◽

Edy Ippolito ◽

Paolo Matteucci ◽

Bianca Santo ◽

Emma Gangemi ◽

...

Keyword(s):

Breast Cancer ◽

Case Report ◽

Brain Metastases ◽

Cancer Patient ◽

Breast Cancer Patient ◽

Radiation Treatment ◽

Her2 Positive ◽

Diffuse Brain ◽

Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials

BMJ Open ◽

10.1136/bmjopen-2016-013053 ◽

2017 ◽

Vol 7 (3) ◽

pp. e013053 ◽

Cited By ~ 18

Author(s):

Zhi-qiao Xu ◽

Yan Zhang ◽

Ning Li ◽

Pei-jie Liu ◽

Ling Gao ◽

...

Keyword(s):

Breast Cancer ◽

Systematic Review ◽

Randomised Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Efficacy And Safety ◽

Her2 Positive ◽

Randomised Controlled ◽

Retinal metastases treated with lapatinib (L) in a young HER2-positive breast cancer patient: Case report

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.12008 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 12008-12008

Author(s):

M. Sarti ◽

O. Pagani ◽

F. Bertoni ◽

S. Longhi ◽

C. Cafaro ◽

...

Keyword(s):

Breast Cancer ◽

Case Report ◽

Cancer Patient ◽

Breast Cancer Patient ◽

Patient Case ◽

Her2 Positive ◽

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases

ESMO Open ◽

10.1136/esmoopen-2017-000253 ◽

2017 ◽

Vol 2 (4) ◽

pp. e000253 ◽

Cited By ~ 28

Author(s):

Giulia Siravegna ◽

Elena Geuna ◽

Benedetta Mussolin ◽

Giovanni Crisafulli ◽

Alice Bartolini ◽

...

Keyword(s):

Breast Cancer ◽

Cerebrospinal Fluid ◽

Brain Metastases ◽

Cancer Patient ◽

Breast Cancer Patient ◽

Her2 Positive ◽

Efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis

Expert Opinion on Drug Safety ◽

10.1080/14740338.2018.1394454 ◽

2017 ◽

Vol 17 (1) ◽

pp. 1-7 ◽

Cited By ~ 8

Author(s):

Henry W. C. Leung ◽

John-Hang Leung ◽

Agnes L. F. Chan

Keyword(s):

Breast Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Targeted Agents ◽

Efficacy And Safety ◽

First Line ◽

Her2 Positive ◽

First Line Treatment ◽

Efficacy of nab-paclitaxel plus trastuzumab in a long-surviving heavily pretreated HER2-positive breast cancer patient with brain metastases

OncoTargets and Therapy ◽

10.2147/ott.s74110 ◽

2015 ◽

pp. 289

Author(s):

Vincenzo Adamo ◽

Giuseppina Rosaria Rita Ricciardi ◽

Alessandro Russo ◽

Tindara Franchina ◽

Giuseppa Ferraro

Keyword(s):

Breast Cancer ◽

Brain Metastases ◽

Cancer Patient ◽

Breast Cancer Patient ◽

Her2 Positive ◽

Heavily Pretreated ◽

Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis

Expert Opinion on Drug Safety ◽

10.1080/17446651.2018.1545367 ◽

2018 ◽

Vol 17 (12) ◽

pp. 1151-1152

Author(s):

Fubin Feng ◽

Fang Yin ◽

Tingting Zhang ◽

Cun Liu ◽

Changgang Sun

Keyword(s):

Breast Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Targeted Agents ◽

Efficacy And Safety ◽

First Line ◽

Her2 Positive ◽

First Line Treatment ◽

Reply to Letter to the editor: efficacy and safety of a combination of HER2-targeted agents as first-line treatment for metastatic HER2-positive breast cancer: a network meta-analysis

Expert Opinion on Drug Safety ◽

10.1080/14740338.2018.1545380 ◽

2018 ◽

Vol 17 (12) ◽

pp. 1153-1153

Author(s):

Henry W. C. Leung ◽

John-Hang Leung ◽

Agnes L. F. Chan

Keyword(s):

Breast Cancer ◽

Meta Analysis ◽

Line Treatment ◽

Targeted Agents ◽

Efficacy And Safety ◽

First Line ◽

Her2 Positive ◽

First Line Treatment ◽

Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

The Lancet Oncology ◽

10.1016/s1470-2045(21)00288-6 ◽

2021 ◽

Vol 22 (8) ◽

pp. 1139-1150

Author(s):

Rosie Bradley ◽

Jeremy Braybrooke ◽

Richard Gray ◽

Robert Hills ◽

Zulian Liu ◽

...

Keyword(s):

Breast Cancer ◽

Early Stage ◽

Meta Analysis ◽

Randomised Trials ◽

Her2 Positive ◽